Omega Funds — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Beta Bionics, Incbetabionics.cominNASDAQ: BBNXSep 2023SEC filingmedium confidence
Beta Bionics develops the iLet Bionic Pancreas System, an insulin delivery device for people with type 1 diabetes aged 6 and older that requires a physician's prescription.
Digital HealthHealthtechMedical DevicesIrvine, US
Edward Damiano(Executive Officer, Director)Gilbert Clarke(Executive Officer)Edward Raskin(Executive Officer, Director)Mike Roskino(Executive Officer)Agustin Mohedas(Director)Jeff Hitchcock(Director)
Board seatFrancesco Draetta· per SEC Form D · $101.8M raise · filed Sep 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.